Production & Sales - Marketing & Sales

Moderna announces supply agreement with UK government to supply Covid-19 mRNA vaccine

Moderna, a new generation of transformative medicines for patients, today announced a supply agreement with the UK government to supply mRNA-1273, its Covid-19 vaccine candidate, beginning in March 2021 if it is approved for use by UK regulatory authorities.

Cheplapharm to buy AstraZeneca’s heart failure and hypertension drugs for $400m

Cheplapharm Arzneimittel has agreed to acquire commercial rights of heart failure and hypertension drugs from AstraZeneca in a deal valued at around $400m.

Eli Lilly secures $375m contract from US government to supply Covid-19 drug

Eli Lilly has secured a $375m contract from the US government to supply 300,000 doses of its bamlanivimab (LY-CoV555) 700mg investigational neutralising antibody to fight against Covid-19.

GSK, Sanofi to supply 200 million doses of Covid-19 vaccine to COVAX

GlaxoSmithKline (GSK) and Sanofi have entered into a statement of intent with Gavi to supply 200 million doses of their adjuvanted recombinant protein-based Covid-19 vaccine to the COVAX Facility.

Moderna to supply Qatar with mRNA vaccine against Covid-19

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support the Ministry’s ongoing efforts to secure early access to a safe and effective COVID-19 vaccine for the people of Qatar.

Vifor Pharma, Cara Therapeutics to commercialise kidney disease drug Korsuva in US

Vifor Pharma has entered into a licence agreement with Cara Therapeutics to commercialise Korsuva (difelikefalin) to treat chronic kidney disease-associated pruritus (CKD-aP) in the US.

World Bank sanctions $12bn to help countries access Covid-19 vaccines

The World Bank has sanctioned a package of $12bn for developing nations towards the purchase and distribution of Covid-19 vaccines, treatments, and tests.

Janssen Pharmaceutical to supply up to 400 million Covid-19 vaccine doses to EU

European Commission (EC) has approved an advance purchase agreement under which Janssen Pharmaceutical Companies will supply up to 400 million doses of its Covid-19 vaccine candidate.

Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted Covid-19 vaccine, beginning in 2021.